From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q2 2023 call → NOWe need to determine if management describes a recent crossing into an approved/specified/listed status that will bring future business without discrete selling events, and that this is new with most volume ahead. Scan transcript for relevant terms: "approved", "specified", "listed", "qualified", "registered", "reimbursed", "pre-authorized", "preferred supplier", "procurement", "formulary", "catalog", "network", "roster", "standard", "default", "inside the pathway", "friction", "without a discrete selling event". Look for mentions of being placed into a buyer's system. The transcript mentions Salesforce partnership, but that's a reseller/distribution? Actually, they talk about "Social Studio opportunity" and "standard social platform for all Salesforce customers". That could be a form of being specified? But is it recent? They say "accelerated momentum" and "onboarded a record 176 logos" - that's still individual wins? They mention "we continue to expect contributions to grow meaningfully and linearly over the course of 2023 building to a very strong Q4 as the largest and most complex deployments begin to make their migration over to Sprout." That suggests they are winning customers, not that they are now a default in a system. Also mention of "influencer marketing" and Tagger acquisition, but that's not about being placed into a buyer's system. The question asks specifically about the company having recently crossed from candidate to approved/specified/listed etc. inside buyers' own purchasing systems, so that future business arrives without a discrete selling event. Management does not describe such a status. They talk about "record new business ACVs", "enterprise grew nearly 50%", "RPO growth", but nothing about being placed on a list or being written into specifications. The Salesforce partnership might be a distribution channel, but it's not described as a new status that eliminates selling events. They still have to onboard logos individually. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.